• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: AD

Future uncertain for active immunotherapies in AD – Part 1

December 10, 2014  

Novel theory proposed for AD

September 3, 2014  

Amyloid-beta in CSF: meta-analysis of accuracy in diagnosis

August 20, 2014  

Clinical trials in Alzheimer’s disease: three recent setbacks

April 23, 2014  

Fingolimod: impact on beta-amyloid neurotoxicity?

March 19, 2014  

Neurodegenerative disease and high-voltage power lines

March 5, 2014  

Inappropriate prescribing common in AD patients

November 13, 2013  

Increased risk of relapse with risperidone discontinuation in AD

October 23, 2013  

Apathy in Alzheimer’s disease a mortality risk factor

May 15, 2013  

Effect of walking on cognitive function in Alzheimer’s disease

April 24, 2013  
Previous
1
2
3
4
5
Next

Browse by Topic

  • EPILEPSY (36)
  • MS (412)
  • CLINICAL CASES IN MS (15)
  • BIOMARKERS IN MS (54)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • Library (17)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Treatment discontinuation in MS: the DOT-MS trial posted on May 5, 2025
  • AAN 2025 – report on fluid biomarkers in MS posted on April 22, 2025
  • McDonald criteria 2024: what changes can we expect? posted on January 30, 2024
Copyright 2025 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions